News | Susan G. Komen®️

Susan G. Komen Newsroom

Get the latest news and updates from Susan G. Komen

All News

News Releases

Susan G. Komen® Expresses Disappointment Over Veto of Bill to Expand Breast, Cervical Care in California

October 1, 2024

Susan G. Komen® Urges All Women to Know Their Breast Cancer Risk and Take Action; New Data Confirms Disease Affects More Young Women

October 1, 2024

Susan G. Komen® to Host MORE THAN PINK Walk in Austin this Fall

September 26, 2024

Susan G. Komen® to Host More Than Pink Walk in Northwest Arkansas this Fall

September 26, 2024

Susan G. Komen® to Host MORE THAN PINK Walk in Georgia this Fall

September 26, 2024

Susan G. Komen® Announces Upcoming Dates and Locations for New England MORE THAN PINK Walks

September 25, 2024

Susan G. Komen(R) to Host MORE THAN PINK Walk in Los Angeles this Fall

September 20, 2024

Susan G. Komen(R) to Host MORE THAN PINK Walk in Colorado this Fall

September 20, 2024

1 2 3 4 5 6 … 32

Recent Podcasts

[00:00:00] Adam Walker: From Susan G Komen, this is Real Pink. A podcast exploring real stories, struggles, and triumphs related to breast cancer. We’re taking the conversation from the doctor’s office to your living room. [00:00:17] This is Real Talk, a podcast conversation where we’re digging deep into breast cancer and the realities patients and…

Getting to YesMon, 25 Nov 2024
On today’s episode, we are discussing a topic that affects most women with hormone receptor-positive, early-stage breast cancer after they finish their initial treatment and begin navigating survivorship. To lower the risk of recurrence, most women begin taking anti-estrogen therapy, also called hormone therapy or endocrine therapy, but these treatments do not come without the risk of side effects. When side effects become severe, survivors may be faced with the task of weighing the benefits of hormone therapy against the associated side effects. This can be challenging and may even lead them to wonder how much longer they need to continue on the medication. Joining us today to discuss how patients and providers can balance fear of recurrence against potential side effects of treatment and how genomic testing can help guide treatment decisions is a Nurse Practitioner at Memorial Sloan-Kettering Cancer Center, Adriana Olivo.

Balancing Fear of Recurrence vs. Treatment Side Effects in SurvivorshipMon, 18 Nov 2024
[00:00:00] Adam Walker: This episode of the Real Pink Podcast is brought to you by AstraZeneca. AstraZeneca is leading a revolution in oncology with the ambition to provide cures for cancer in every form, following the science to understand cancer and all of its complexities to discover, develop, and deliver life changing medicines to patients.…

How Political Determinants of Health Impact Us AllMon, 11 Nov 2024